
ICLR · NASDAQ
ICON Public Limited Company
$212.97 +29.99 (+16.39%)
Company overview
ICON Public Limited Company is a clinical research organization that provides outsourced development and commercialization services in Ireland, the rest of Europe, the United States, and internationally. The company specializes in the strategic development and management and analysis of programs that support various stages of the clinical development process from compound selection through Phase I-IV clinical studies. It offers clinical development services including early development, patient recruitment and retention, strategy and analytics, late-phase research, data and technology solutions, and consulting and analytics services.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Exchange
- NASDAQ
- Market cap
- $16.4B
- Employees
- 41,250
- Headquarters
- Dublin
- Website
- iconplc.com
- CEO
- Barry Balfe
- Listed
- May 15, 1998
- P/E
- 74.72
- Dividend yield
- 0.00%
Company financials
- Revenue
- $8.2B
- Gross profit
- $2.1B
- Operating income
- $898M
- EBITDA
- $1.3B
- Net income
- $489M
- EPS
- $2.85
- Total assets
- $16.3B
- Total debt
- $3.6B
- Gross margin
- 25.16%
- Net margin
- 5.98%
- Earnings yield
- 1.34%
No product segmentation.
Showing FY 2025